12/14/2009

The FDA released its final rule on current good manufacturing practices covering all PET drugs, which will take effect Dec. 12, 2011. The agency will require developers of PET radiopharmaceuticals to submit new-drug or abbreviated new-drug applications in the two-year period before implementation.

Related Summaries